Curaleaf price target lowered to C$5 from C$6.50 at Alliance Global Partners

Alliance Global Partners lowered the firm’s price target on Curaleaf (CURLF) to C$5 from C$6.50 and keeps a Buy rating on the shares. Curaleaf reported a “roughly in-line” quarter as sales came in slightly below estimates and guided Q1 down mid-single digits due to seasonality, the analyst noted. The firm continues to see Curaleaf as the largest player in the cannabis space with exposure to what Alliance views as two notable growth opportunities in hemp beverages and international during a time of regulatory uncertainty around cannabis, the analyst added.